Clincosm LogoSign in Get a demo

clinical stage iv cutaneous melanoma ajcc v8

Showing 26 - 44 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +19 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 19, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United

Recruiting
  • AIDS-Related Non-Hodgkin Lymphoma
  • +29 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Birmingham, Alabama
  • +12 more
Aug 4, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Hematopoietic and Lymphoid Cell Tumor

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +13 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Microbiome on Immune Checkpoint Inhibitor Response in Melanoma

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 31, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Ipilimumab
  • Nivolumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
May 6, 2022

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +8 more
  • Ipilimumab
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Houston

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Pharmacogenomics Testing in Directing Optimal Use of Supportive

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +45 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Feb 3, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States

Recruiting
  • Acral Lentiginous Melanoma
  • +6 more
  • Birmingham, Alabama
  • +309 more
Nov 8, 2021

Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

Recruiting
  • Advanced Endometrial Carcinoma
  • +36 more
  • Glutaminase Inhibitor IPN60090
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 9, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Bone Loss in Melanoma Survivors Receiving Immunotherapy

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Biospecimen Collection
  • Dual X-ray Absorptiometry
  • Houston, Texas
    M D Anderson Cancer Center
Aug 2, 2021

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Dietary Intervention
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2021